Mete O, Wenig BM. (2022) Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms. Head Neck Pathol. https://doi.org/10.1007/s12105-022-01435-8.

Uccella S, Ottini G, Facco C, Maragliano R, Asioli S, Sessa F, La Rosa S. (2017) Neuroendocrine neoplasms of the head and neck and olfactory neuroblastoma. Diagnosis and classification. Pathologica. 109(1):14-30.

CAS  PubMed  Google Scholar 

Uccella S, La Rosa S. (2020) Looking into digestive mixed neuroendocrine - nonneuroendocrine neoplasms: subtypes, prognosis, and predictive factors. Histopathology. 77(5):700-717. doi: https://doi.org/10.1111/his.14178.

Article  PubMed  Google Scholar 

La Rosa S, Sessa F, Uccella S. (2016) Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms. EndocrPathol. 27(4):284-311. doi: https://doi.org/10.1007/s12022-016-9432-9.

CAS  Article  Google Scholar 

Libera L, Ottini G, Sahnane N, Pettenon F, Turri-Zanoni M, Lambertoni A, Chiaravalli AM, Leone F, Battaglia P, Castelnuovo P, Uccella S, Furlan D, Facco C, Sessa F. (2021) Methylation Drivers and Prognostic Implications in Sinonasal Poorly Differentiated Carcinomas. Cancers (Basel). 13(19):5030.

Turri-Zanoni M, Maragliano R, Battaglia P, Giovannardi M, Antognoni P, Lombardi D, Morassi ML, Pasquini E, Tarchini P, Asioli S, Foschini MP, Sessa F, Nicolai P, Castelnuovo P, La Rosa S. (2017) The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival. Oral Oncol. 74:21-29. doi: https://doi.org/10.1016/j.oraloncology.2017.09.010.

Article  PubMed  Google Scholar 

Bell D, Saade R, Roberts D, Ow TJ, Kupferman M, DeMonte F, Hanna EY. (2015) Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol. 9(1):51-9. doi: https://doi.org/10.1007/s12105-014-0547-3.

Article  PubMed  Google Scholar 

Capper D, Engel NW, Stichel D, Lechner M, Glöss S, Schmid S, Koelsche C, Schrimpf D, Niesen J, Wefers AK, Jones DTW, Sill M, Weigert O, Ligon KL, Olar A, Koch A, Forster M, Moran S, Tirado OM, Sáinz-Jaspeado M, Mora J, Esteller M, Alonso J, Del Muro XG, Paulus W, Felsberg J, Reifenberger G, Glatzel M, Frank S, Monoranu CM, Lund VJ, von Deimling A, Pfister S, Buslei R, Ribbat-Idel J, Perner S, Gudziol V, Meinhardt M, Schüller U. (2018) DNA methylation-based reclassification of olfactory neuroblastoma. Acta Neuropathol. 136(2):255-271. doi: https://doi.org/10.1007/s00401-018-1854-7.

CAS  Article  PubMed  Google Scholar 

Magnusson K, de Wit M, Brennan DJ, Johnson LB, McGee SF, Lundberg E, Naicker K, Klinger R, Kampf C, Asplund A, Wester K, Gry M, Bjartell A, Gallagher WM, Rexhepaj E, Kilpinen S, Kallioniemi OP, Belt E, Goos J, Meijer G, Birgisson H, Glimelius B, Borrebaeck CA, Navani S, Uhlén M, O'Connor DP, Jirström K, Pontén F. (2011) SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas. Am J Surg Pathol. 35(7):937-48. doi: https://doi.org/10.1097/PAS.0b013e31821c3dae.

Article  PubMed  Google Scholar 

Meagher NS, Wang L, Rambau PF, Intermaggio MP, Huntsman DG, Wilkens LR, El-Bahrawy MA, Ness RB, Odunsi K, Steed H, Herpel E, Anglesio MS, Zhang B, Lambie N, Swerdlow AJ, Lubiński J, Vierkant RA, Goode EL, Menon U, Toloczko-Grabarek A, Oszurek O, Bilic S, Talhouk A, García-Closas M, Wang Q, Tan A, Farrell R, Kennedy CJ, Jimenez-Linan M, Sundfeldt K, Etter JL, Menkiszak J, Goodman MT, Klonowski P, Leung Y, Winham SJ, Moysich KB, Behrens S, Kluz T, Edwards RP, Gronwald J, Modugno F, Hernandez BY, Chow C, Kelemen LE, Keeney GL, Carney ME, Natanzon Y, Robertson G, Sharma R, Gayther SA, Alsop J, Luk H, Karpinskyj C, Campbell I, Sinn P, Gentry-Maharaj A, Coulson P, Chang-Claude J, Shah M, Widschwendter M, Tang K, Schoemaker MJ, Koziak JM, Cook LS, Brenton JD, Daley F, Kristjansdottir B, Mateoiu C, Larson MC, Harnett PR, Jung A, deFazio A, Gorringe KL, Pharoah PDP, Minoo P, Stewart C, Bathe OF, Gui X, Cohen P, Ramus SJ, Köbel M. (2019) A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases. Mod Pathol. 32(12):1834-1846. doi: https://doi.org/10.1038/s41379-019-0302-0.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Kriegsmann M, Harms A, Longuespée R, Muley T, Winter H, Kriegsmann K, Kazdal D, Goeppert B, Pathil A, Warth A. (2018) Role of conventional immunomarkers, HNF4-α and SATB2, in the differential diagnosis of pulmonary and colorectal adenocarcinomas. Histopathology. 72(6):997-1006. doi: https://doi.org/10.1111/his.13455.

Article  PubMed  Google Scholar 

Bellizzi AM. (2020) SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas. Histopathology. 76(2):251-264. doi: https://doi.org/10.1111/his.13943.

Article  PubMed  Google Scholar 

Hoskoppal D, Epstein JI, Gown AM, Arnold Egloff SA, Gordetsky JB, Shi CJ, Giannico GA. (2020) SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours. Histopathology. 76(4):550-559. doi: https://doi.org/10.1111/his.14012.

Article  PubMed  Google Scholar 

Mohanty SK, Tiwari A, Bhardwaj N, Chuang F, Kim E, Lugo H, Yuan X, Diffalha SA, Peralta-Venturina M, Balzer B, Dhall D. (2021) Positivity for SATB2 distinguishes Islet1 positive rectal neuroendocrine tumours from pancreaticoduodenal neuroendocrine tumours. J Clin Pathol. 74(9):582-588. doi: https://doi.org/10.1136/jclinpath-2020-206645.

CAS  Article  PubMed  Google Scholar 

Asa SL, Arkun K, Tischler AS, Qamar A, Deng FM, Perez-Ordonez B, Weinreb I, Bishop JA, Wenig BM, Mete O. (2021) Middle Ear "Adenoma": a Neuroendocrine Tumor with Predominant L Cell Differentiation. EndocrPathol. 32(4):433-441. doi: https://doi.org/10.1007/s12022-021-09684-z.

CAS  Article  Google Scholar 

Kervarrec T, Tallet A, Miquelestorena-Standley E, Houben R, Schrama D, Gambichler T, Berthon P, Le Corre Y, Hainaut-Wierzbicka E, Aubin F, Bens G, Tabareau-Delalande F, Beneton N, Fromont G, Arbion F, Leteurtre E, Touzé A, Samimi M, Guyétant S. (2019) Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomas. Mod Pathol. 32(4):499-510. doi: https://doi.org/10.1038/s41379-018-0155-y.

CAS  Article  PubMed  Google Scholar 

Fukuhara M, Agnarsdóttir M, Edqvist PH, Coter A, Ponten F. (2016) SATB2 is expressed in Merkel cell carcinoma. Arch Dermatol Res. 308(6):449-54. doi: https://doi.org/10.1007/s00403-016-1655-6.

CAS  Article  PubMed  Google Scholar 

Perrino CM, Ho A, Dall CP, Zynger DL. Utility of GATA3 in the differential diagnosis of pheochromocytoma. (2017) Histopathology. 71(3):475-479. doi: https://doi.org/10.1111/his.13229.

Article  PubMed  Google Scholar 

Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, Busam KJ, de Krijger RR, Dietel M, El-Naggar AK, Fernandez-Cuesta L, Klöppel G, McCluggage WG, Moch H, Ohgaki H, Rakha EA, Reed NS, Rous BA, Sasano H, Scarpa A, Scoazec JY, Travis WD, Tallini G, Trouillas J, van Krieken JH, Cree IA. (2018) A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol. 31(12):1770-1786. doi: https://doi.org/10.1038/s41379-018-0110-y.

Article  PubMed  PubMed Central  Google Scholar 

Sjöstedt E, Zhong W, Fagerberg L, Karlsson M, Mitsios N, Adori C, Oksvold P, Edfors F, Limiszewska A, Hikmet F, Huang J, Du Y, Lin L, Dong Z, Yang L, Liu X, Jiang H, Xu X, Wang J, Yang H, Bolund L, Mardinoglu A, Zhang C, von Feilitzen K, Lindskog C, Pontén F, Luo Y, Hökfelt T, Uhlén M, Mulder J. (2020) An atlas of the protein-coding genes in the human, pig, and mouse brain. Science. 367(6482):eaay5947. doi: https://doi.org/10.1126/science.aay5947.

Human Protein Atlas proteinatlas.orghttps://www.proteinatlas.org/ENSG00000119042-SATB2/brain.

Jarvie BC, Chen JY, King HO, Palmiter RD. (2021) Satb2 neurons in the parabrachial nucleus mediate taste perception. Nat Commun. 12(1):224. doi: https://doi.org/10.1038/s41467-020-20100-8.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Huang X, Chen Q, Luo W, Pakvasa M, Zhang Y, Zheng L, Li S, Yang Z, Zeng H, Liang F, Zhang F, Hu DA, Qin KH, Wang EJ, Qin DS, Reid RR, He TC, Athiviraham A, El Dafrawy M, Zhang H. (2020) SATB2: A versatile transcriptional regulator of craniofacial and skeleton development, neurogenesis and tumorigenesis, and its applications in regenerative medicine. Genes Dis. 9(1):95-107. doi: https://doi.org/10.1016/j.gendis.2020.10.003.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Malouf GG, Casiraghi O, Deutsch E, Guigay J, Temam S, Bourhis J. (2013) Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome. Eur J Cancer. 49(6):1324-34. doi: https://doi.org/10.1016/j.ejca.2012.12.008.

Article  PubMed  Google Scholar 

Classe M, Yao H, Mouawad R, Creighton CJ, Burgess A, Allanic F, Wassef M, Leroy X, Verillaud B, Mortuaire G, Bielle F, Le Tourneau C, Kurtz JE, Khayat D, Su X, Malouf GG. (2018) Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny. Cell Rep. 25(3):811-821.e5. doi: https://doi.org/10.1016/j.celrep.2018.09.047.

CAS  Article  PubMed  Google Scholar 

Kaur RP, Izumchenko E, Blakaj DM, Mladkova N, Lechner M, Beaumont TL, Floudas CS, Gallia GL, London NR Jr. (2021) The genomics and epigenetics of olfactory neuroblastoma: A systematic review. Laryngoscope Investig Otolaryngol. 6(4):721-728. doi: https://doi.org/10.1002/lio2.597.

Article  PubMed  PubMed Central  Google Scholar 

Romani C, Bignotti E, Mattavelli D, Bozzola A, Lorini L, Tomasoni M, Ardighieri L, Rampinelli V, Paderno A, Battocchio S, Gurizzan C, Castelnuovo P, Turri-Zanoni M, Facco C, Sessa F, Schreiber A, Ferrari M, Ravaggi A, Deganello A, Nicolai P, Buglione M, Tomasini D, Maroldi R, Piazza C, Calza S, Bossi P. (2021) Gene Expression Profiling of Olfactory Neuroblastoma Helps Identify Prognostic Pathways and Define Potentially Therapeutic Targets. Cancers (Basel). 13(11):2527. doi: https://doi.org/10.3390/cancers13112527.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Miettinen M, McCue PA, Sarlomo-Rikala M, Rys J, Czapiewski P, Wazny K, Langfort R, Waloszczyk P, Biernat W, Lasota J, Wang Z. (2014) GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol. 38(1):13-22. doi: https://doi.org/10.1097/PAS.0b013e3182a0218f.

Article  PubMed  PubMed Central  Google Scholar 

Nonaka D, Wang BY, Edmondson D, Beckett E, Sun CC. (2013) A study of gata3 and phox2b expression in tumors of the autonomic nervous system. Am J Surg Pathol. 37(8):1236-41. doi: https://doi.org/10.1097/PAS.0b013e318289c765.

Article  PubMed  Google Scholar 

Mete O, Kefeli M, Çalışkan S, Asa SL. (2019) GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors. Mod Pathol. Apr;32(4):484–489. doi: https://doi.org/10.1038/s41379-018-0167-7.

Schwartz LE, Begum S, Westra WH, Bishop JA. (2013) GATA3 immunohistochemical expression in salivary gland neoplasms. Head Neck Pathol. 7(4):311-5. doi: https://doi.org/10.1007/s12105-013-0442-3.

Article  PubMed  PubMed Central  Google Scholar